Progyny, Inc. (NASDAQ: PGNY)

Progyny, Inc. provides fertility and family building benefits solutions to employers across the United States. The company designs and administers comprehensive benefits programs that include fertility treatment, pregnancy and postpartum care, menopause support, and related wellness services. The platform integrates benefits design, member education and support, and active management of a selective network of healthcare providers. The company’s mission is to empower healthier, supported journeys through transformative fertility, family building and women’s health benefits. Progyny launched its fertility benefits solution in 2016 with five employer clients and has since expanded its platform to address the full continuum of women’s health.

Progyny generates revenue primarily through fees paid by employer clients for administering its benefits solutions. These fees are typically based on the number of covered lives enrolled in the program and the specific services selected, such as fertility cycles, pharmacy benefits, or additional wellness programs. The company also earns revenue from its integrated pharmacy benefit offering, Progyny Rx, which is billed alongside the core fertility benefits. Revenue is recognized ratably over the service period as the company provides ongoing support and claims administration. The firm also collects fees for implementation and setup when a new client enrolls in the program. Ongoing revenue includes per member per month charges for access to care management services, digital tools, and clinical support. Revenue from the pharmacy benefit is driven by the volume of prescriptions filled through the Progyny Rx network and associated dispensing fees.

Progyny holds a leading position in the employer sponsored women's health and fertility benefits market. It differentiates itself through a data driven platform that delivers superior clinical outcomes such as higher live birth rates, and lower multiple birth rates compared with national averages. The company’s competitive advantages include access to a broad network of high quality fertility specialists, a proprietary benefits design known as the Smart Cycle, and an integrated pharmacy solution that simplifies medication management. Progyny reports strong client retention and high satisfaction scores, with a Net Promoter Score of +81 for its fertility benefit and +79 for its pharmacy offering as of December 31, 2025. Progyny’s proprietary Smart Cycle design standardizes fertility treatment bundles and provides members with predictable access to a full cycle of care. The company collects extensive clinical and utilization data directly from providers, which informs network quality standards and helps improve patient outcomes. These capabilities allow Progyny to claim a competitive edge in delivering cost effective solutions while maintaining high levels of member satisfaction.

Progyny serves more than 590 employer clients across over 40 industries including technology, consumer retail, health care, financial services, and manufacturing. These clients collectively represent approximately 7.2 million covered lives, each employer having at least 1,000 eligible employees. Progyny’s customer base comprises large self insured employers that provide benefits to at least 1,000 workers and span sectors such as technology, finance, and manufacturing. Contracts with employers typically run for multiple years and renew automatically unless either party opts out. Progyny reports that a substantial majority of its clients have remained with the company since the initial launch of its fertility benefit in 2016. The employer base spans a wide geography, with participants located in virtually every state across the United States.